Cannabinoid company Zelira Therapeutics (ASX:ZLD) has announced the appointment of Dr Donna Gentile O’Donnell as a non-executive director.
Dr O’Donnell served as special assistant to the president of Thomas Jefferson University and is the senior vice president for innovation partnerships and programs.
Dr O’Donnell has led a diverse and successful career in health care, life sciences and public service. She was formerly a principal with O’Donnell Associates, and her clients included non-profit organisations, universities, and life science companies, including Cephalon Pharmaceuticals.
As former president of Franklin Health Trust, Dr O’Donnell was instrumental in leading the negotiations to merge $50 million of the foundation’s assets into the Drexel University College of Medicine.
Zelira also announced that Lisa Gray has resigned as a non-executive director effective.
